| 1 | 11C-PBR28 | - | - | - | - | [2] 6 6, 13 |
| 2 | 11C]PBR28 | - | - | - | - | [1] 6 6 |
| 3 | 18F-PM-PBB3 | - | - | - | - | [1] 13 13 |
| 4 | 4-PBA | - | - | - | - | [1] 231 231 |
| 5 | [18F] PBR06 | - | - | - | - | [2] 6 6, 13 |
| 6 | [18F]PBR06 | - | - | - | - | [1] 2 2 |
| 7 | [C-11]PBR28 | - | - | - | - | [1] 13 13 |
| 8 | [F-18]PBR06 | - | - | - | - | [2] 13 13, 17 |
| 9 | ADA PBSC | - | - | - | - | [1] 65 65 |
| 10 | CD34 selected haploidentical PBSCT | - | - | - | - | [1] 285 285 |
| 11 | Donor mobilized PBSC infusion | - | - | - | - | [2] 60 60, 285 |
| 12 | ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients) | - | - | - | - | [1] 13 13 |
| 13 | Other: Donor derived G-CSF mobilized PBC | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 60 60 |
| 14 | Other: PBO | - | - | - | - | [1] 162 162 |
| 15 | PB | - | - | - | - | [2] 67 67, 225 |
| 16 | PB006 | - | - | - | - | [1] 13 13 |
| 17 | PB1046 | - | - | - | - | [1] 86 86 |
| 18 | PB1046 Injection | - | - | - | - | [1] 113 113 |
| 19 | PB1046 Subcutaneous Injection | - | - | - | - | [1] 86 86 |
| 20 | PB1046, VIP-ELP1-120, Vasomera | - | - | - | - | [1] 86 86 |
| 21 | PBA | - | - | - | - | [1] 231 231 |
| 22 | PBF-509 | - | - | - | - | [1] 6 6 |
| 23 | PBF-677 | - | - | - | - | [1] 97 97 |
| 24 | PBF-999 | - | - | - | - | [1] 8 8 |
| 25 | PBF-999 / 160 mg | - | - | - | - | [1] 8 8 |
| 26 | PBF-999 / 320 mg | - | - | - | - | [1] 8 8 |
| 27 | PBFT02 | - | - | - | - | [1] 127 127 |
| 28 | PBGM01 | - | - | - | - | [1] 19 19 |
| 29 | PBI4050 | - | - | - | - | [2] 85 85, 299 |
| 30 | PBKR03 | - | - | - | - | [1] 19 19 |
| 31 | PBMC autotransplantation | - | - | - | - | [1] 2 2 |
| 32 | PBT2 | - | - | - | - | [1] 8 8 |
| 33 | Pemziviptadil (PB1046) | - | - | - | - | [1] 86 86 |
| 34 | Pemziviptadil (PB1046) Injection | - | - | - | - | [1] 86 86 |
| 35 | Peripheral blood stem cell transplantation (PBSCT) | - | - | - | - | [1] 60 60 |
| 36 | Radiation: PET/MR with [11C]PBR28 | - | - | - | - | [1] 6 6 |
| 37 | Unrelated PBSC with T cell depletion | - | - | - | - | [1] 65 65 |
| 38 | Vasomera (PB1046) Injection | - | - | - | - | [1] 86 86 |